Stanford Cancer Institute




Event Details

Advances in Mass Spectrometry Enabled Drug Discovery

calendar October 29, 2024 8:00 AM to 5:30 PM
location

Jen-Hsun Huang Engineering Center
Mackenzie Room, 3rd Floor
475 Via Ortega
Stanford,   CA  94305


Advances in Mass Spectrometry Enabled Drug Discovery

The inaugural Stanford Cancer Institute Advances in Mass Spectrometry Enabled Drug Discovery symposium on October 29, 2024 will bring together leading experts in academia and industry to explore current challenges and opportunities and recent achievements across diverse applications in drug development. 

This field has revolutionized ligand and target discovery by enabling the detection of interactions proteome-wide. Chemoproteomic techniques targeting reactive residues have grown and expanded the scope of covalent ligand discovery. Mass spectrometry instrumentation continues to improve, deepening proteomic coverage, accuracy, and sensitivity while becoming more accessible.

The symposium is open to Stanford faculty, students, and postgraduates, as well as those outside of Stanford who are interested in diving into the cutting-edge world of proteomics. Join us for this all-day dynamic learning experience to discuss the exciting progress in mass spectrometry-based proteomics.

 

8:00 - 8:20 am

Registration Open & Continental Breakfast

8:20 - 8:30 am

Welcome

 

Nathanael Gray, PhD
Stanford University  

 

8:30 - 10:10 am

SESSION I: Using mass spectrometry platforms for ligand discovery | Chair: Nathanael Gray, PhD

 

Matt Patricelli, PhD
Vividion Therapeutics

 

Sherry Niessen, PhD
Belharra Therapeutics

 

Katelyn Cassidy, PhD
C4 Therapeutics

 

Paola Castaldi, PhD
Matchpoint Therapeutics

 

10:10- 10:35 am

Session 1 Panel Discussion
 

10:35 -10:45 am

Break

10:45 - 11:35 am

SESSION 2: Expanding covalency in drug design | Chair: Matt Patricelli, PhD

 

Kevan Shokat, PhD 
UCSF
 

 

Jack Taunton, PhD
UCSF
 

11:35 - 11:55 am

Session 2 Panel Discussion
 

12:00 - 1:00 pm

Lunch

1:00 - 1:50 pm

SESSION 3: MS Technology & Discovery Proteomics | Chair: Nathanael Gray, PhD

 

Brian Searle, PhD
Ohio State University 

 

Peter Jackson, PhD
Stanford University  

 

1:50 - 2:10 pm

Session 3 Panel Discussion
 

2:10 - 2:50 am

Trainee Lightning Talks  | Chair: Matt Patricelli, PhD

 

Brendan Dwyer, PhD
Stanford University

 

Shizhong Dai, PhD
Stanford University

 

Steven Shuken, PhD
Harvard University
 

2:00 - 2:10 pm

Break

2:10 - 3:25 pm

SESSION 4: Advancing activity-based protein profiling | Chair: Brendan Dwyer, PhD

 

Ben Cravatt, PhD
Scripps Research Institute

 

Keriann Backus, PhD
UCLA

 

Ekaterina Vinogradova, PhD
Rockefeller University
 

3:25 - 3:45 pm

Session 4 Panel Discussion
 

3:45 - 3:55 pm

Break

3:55 - 5:10 pm

SESSION 5: Developing proximity-based therapeutics | Chair: Matt Patricelli, PhD

 

Katherine Donovan, PhD
Dana Farber Cancer Institute

 

Pete Wildes, PhD
Revolution Medicines
 

5:10 - 5:30 PM

Session 5 Panel Discussion
 

5:30 - 5:35 PM

Ending remarks

 

Matt Patricelli, PhD
Vividion Therapeutics  

 

5:35 - 6:15 PM

Reception

Laura Attardi headshot

Keriann Backus, PhD

Assistant Professor, Biological Chemistry, Chemistry and Biochemistry
PI, The Backus Lab
UCLA

James Ford, MD

Katelyn Cassidy, PhD

Senior Proteomics Scientist
Team Leader
C4 Therapeutics

Melinda Telli headshot

Paola Castaldi, PhD

Senior Vice President, Head of Platform and Chemical Biology
Matchpoint Therapeutics

Matt Abrahams headshot

Ben Cravatt, PhD

Professor and Gilula Chair, Chemical Biology
PI, The Cravatt Lab
Scripps Research Institute

Steven Artandi headshot

Katherine Donovan, PhD

Lead Scientist/Managing Director
Fischer Labs
Dana Farber Cancer Institute

Carolyn Bertozzi headshot

Peter Jackson, PhD

Professor of Microbiology and Immunology, Baxter Labs, and of Pathology
Faculty Director, Stanford Cancer Center Proteomics
Faculty Director, Stanford University Mass Spectrometry
PI, The Jackson Lab
Stanford University

Crystal Botham headshot

Sherry Niessen, PhD

Vice President, Head of Platform & Proteomics
Belharra Therapeutics

Brian Searle Headshot

Brian Searle, PhD

Assistant Professor, Department of Biomedical Informatics
Ohio State University Medical Center.
Courtesy Assistant Professor, Department of Chemistry and Biochemistry, Ohio State University

Mark Chao Headshot

Kevan Shokat, PhD

Professor, Department of Cellular and Molelcular Pharmacology
PI, The Shokat Lab
UCSF

Chris Chen headshot

Jack Taunton, PhD

Professor, Cellular Molecular Pharmacology
PI, The Taunton Lab
UCSF

Chris Chen headshot

Ekaterina Vinogradova, PhD

Assistant Professor
Head of Laboratory of Chemical Immunology and Proteomics
PI, The Vinogradova Lab 
Rockefeller University

Katherine Ferrara headshot

Pete Wildes, PhD

Vice President, Cancer Biology 
Revolution Medicine

  • Early bird registration is available until September 3, 2024. 
  • Regular pricing will start September 4, 2024. 
  • Registration will close on October 15, 2024.

Seating is limited. Please register if you are planning to attend.

Register
 

Early Bird Price
May 20 - Sept 3

Regular Price
Sept 4 - Oct 15

Students/Grad Students/Postdocs

$25

$50

Academic (Faculty/Staff)

$50

$75

Industry Professionals

$100

$200

Mackenzie Room, 3rd Floor
Jen-Hsun Huang Engineering Center
475 Via Ortega, Stanford CA 94305

Parking 

There are two parking garages near the Huang Engineering Center. If you are a visitor to campus, you can use ParkMobile in visitor parking areas.  The hourly rate is $4.46 and the daily rate is $35.68. Click here for more information on visitor parking.

Parking Structure 2
285 Panama St, Stanford CA 94305
Visitor parking is available on the ground floor

Roble Field Garage
369 Santa Teresa St, Stanford CA 94305
Underground garage located between Santa Teresa and Panama St

Jen-Hsun Huang Engineering Center building

Jen-Hsun Huang Engineering Center

475 Via Ortega
STANFORD, CA 94305 United States

For information on sponsorship opportunities, please contact Athena Serapio at athena3@stanford.edu.

nathanael gray headshot

Nathanael Gray, PhD

Krishnan-Shah Family Professor, Chemical and Systems Biology
Co-director, Cancer Drug Discovery
Co-leader, Cancer Therapeutics Research Program
Program Leader, Small Molecule Drug Discovery for the Innovative Medicines Accelerator
PI, The Gray Lab
Stanford University

Melinda Telli headshot

Brendan Dwyer, PhD

Postdoctoral Scholar
Stanford Cancer Center
Stanford University